The Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus in the United States: A National Observational Study
Open Access
- 28 February 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 177 (7), 666-674
- https://doi.org/10.1093/aje/kws273
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) can cause major illness and death and impose serious economic costs on patients and hospitals. Community-associated MRSA (CA-MRSA) is a growing problem in US hospitals, which are already dealing with high levels of hospital-associated MRSA (HA-MRSA), but little is known about how patient age and seasonal differences in the incidence of these 2 forms of MRSA affect the epidemic. By using national data on hospitalizations and antibiotic resistance, we estimated the magnitude and trends in annual S. aureus and MRSA hospitalization rates from 2005–2009 by patient age, infection type, and resistance phenotype (CA-MRSA vs. HA-MRSA). Although no statistically significant increase in the hospitalization rate was seen over the study period, the total number of infections increased. In 2009, there were an estimated 463,017 (95% confidence interval: 441,595, 484,439) MRSA-related hospitalizations at a rate of 11.74 (95% confidence interval: 11.20, 12.28) per 1,000 hospitalizations. We observed significant differences in infection type by age, with HA-MRSA–related hospitalizations being more common in older individuals. We also noted significant seasonality in incidence, particularly in children, with CA-MRSA peaking in the late summer and HA-MRSA peaking in the winter, which may be caused by seasonal shifts in antibiotic prescribing patterns.Keywords
This publication has 37 references indexed in Scilit:
- Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort studyThe Lancet Infectious Diseases, 2010
- Community-associated Methicillin-Resistant Staphylococcus aureus in Outpatients, United States, 1999–2006Emerging Infectious Diseases, 2009
- Waves of resistance: Staphylococcus aureus in the antibiotic eraNature Reviews Microbiology, 2009
- Methicillin-Resistant Staphylococcus aureus Central Line–Associated Bloodstream Infections in US Intensive Care Units, 1997-2007JAMA, 2009
- The Arginine Catabolic Mobile Element and Staphylococcal Chromosomal CassettemecLinkage: Convergence of Virulence and Resistance in the USA300 Clone of Methicillin‐ResistantStaphylococcus aureusThe Journal of Infectious Diseases, 2008
- Hospitalizations and Deaths Caused by Methicillin-ResistantStaphylococcus aureus, United States, 1999–2005Emerging Infectious Diseases, 2007
- Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threatThe Lancet, 2006
- The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital ChargesInfection Control & Hospital Epidemiology, 2005
- Risk Factors and Costs Associated With Methicillin-Resistant Staphylococcus aureus Bloodstream InfectionsInfection Control & Hospital Epidemiology, 2004
- Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the CommunityJournal of Clinical Microbiology, 2002